| Title |
Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
|
|---|---|
| Published in |
Investigational New Drugs, September 2007
|
| DOI | 10.1007/s10637-007-9077-0 |
| Pubmed ID | |
| Authors |
Catherine Delbaldo, Eric Raymond, Karina Vera, Luz Hammershaimb, Karen Kaucic, Stéphanie Lozahic, Michel Marty, Sandrine Faivre |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 3% |
| Unknown | 39 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 14 | 35% |
| Researcher | 7 | 18% |
| Student > Bachelor | 3 | 8% |
| Other | 3 | 8% |
| Student > Master | 3 | 8% |
| Other | 4 | 10% |
| Unknown | 6 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 11 | 28% |
| Medicine and Dentistry | 8 | 20% |
| Biochemistry, Genetics and Molecular Biology | 7 | 18% |
| Chemistry | 2 | 5% |
| Immunology and Microbiology | 2 | 5% |
| Other | 3 | 8% |
| Unknown | 7 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#3,919,343
of 26,017,215 outputs
Outputs from Investigational New Drugs
#110
of 1,286 outputs
Outputs of similar age
#10,069
of 86,727 outputs
Outputs of similar age from Investigational New Drugs
#3
of 13 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,286 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 86,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.